UConn Health Study Shows InBios Lyme Test Could Simplify Disease Detection
A new study from UConn Health indicates that InBios International's Lyme Detect™ Multiplex ELISA test may streamline the diagnosis of Lyme disease by simplifying the testing process.
A study conducted by UConn Health suggests that InBios International Inc.'s Lyme Detect™ Multiplex ELISA diagnostic test has the potential to simplify the process for detecting Lyme disease. The research, which focused on a single-step ELISA approach, indicates a possible improvement over current multi-step diagnostic methods.
The findings, published following research conducted in collaboration with InBios, highlight the test's ability to potentially reduce the complexity and time involved in diagnosing Lyme disease. The Lyme Detect™ test is designed to identify multiple biomarkers associated with the disease.
Lyme disease, a bacterial infection transmitted by ticks, can cause a range of symptoms and requires timely diagnosis for effective treatment. Current diagnostic protocols often involve multiple tests and can be time-consuming, potentially delaying patient care.
InBios International Inc. develops diagnostic tests for infectious diseases. The company's collaboration with UConn Health on this study aims to validate the clinical utility of its Lyme disease diagnostic technology.